Follow the Parmax Pharma share price and the full directors' dealings record of the company, a publicly traded company based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Market capitalisation: €490.7m. The latest transaction was disclosed on 19 August 2026 (Disposal). Among the most active insiders: ALKESH M GOPANI. Every trade is accessible without an account.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€363,102
4 ops.
Sell Volume
32Σ signal
Buys n/a€363,102 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,536 of 29,064 companies
16.2
score / 100
Value
19
Quality
14
FCF yld-6.6%
Earn yld-8.4%
EV/EBITDA·
ROE·
Gross mgn18%
Net mgn-34%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.